VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation
Hematological Oncology · 2025
DOI: 10.1002/hon.70049 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hematological Oncology, 2025. Verfasst von Francesco Autore und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy. Hauptthemen laut MEDLINE: Biomarkers, Peripheral Blood Stem Cell Transplantation, POEMS Syndrome, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Overproduction of vascular endothelial growth factor (VEGF) seems to contribute to the pathogenesis, still unclear, of POEMS Syndrome. Our study retrospectively reviewed the clinical and VEGF data from a multicenter Italian cohort of patients affected by POEMS syndrome who underwent to autologous peripheral blood stem cell transplantation (aPBSCT) in order to find an impact on clinical improvement or outcome. Patients with VEGF levels higher than 758 pg/mL were at higher risk of relapse, with sensible difference in PFS ( p = 0.007). VEGF could be used as a marker of relapse and as a marker of disease intensity in patients with POEMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.
- Istituto Clinico Humanitas IRCCS, Rozzano, Italy.
- Azienda Ospedale Università Padova, Padova, Italy.
- S. Giovanni Battista, Torino, Italy.
- SC di Ematologia e CTMO - Oncologico Oncologico di Riferimento Regionale "A. Businco" - ARNAS "G. Brotzu", Cagliari, Italy.
- ASST Spedali Civili, Brescia, Italy.
Zitieren
APA
Autore, F., Mannina, D., Lessi, F., Galli, E., Oliva, S., Derudas, D., Giannotta, C., Crippa, C., Mancuso, K., Marcatti, M., Innocenti, I., Mazza, R., Bramanti, S., & Laurenti, L. (2025). VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation. Hematological Oncology. https://doi.org/10.1002/hon.70049
Vancouver
Autore F, Mannina D, Lessi F, Galli E, Oliva S, Derudas D, et al. VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation. Hematological Oncology. 2025. doi:10.1002/hon.70049
BibTeX
@article{Autore2025,
author = {Autore, Francesco and Mannina, Daniele and Lessi, Federica and Galli, Eugenio and Oliva, Stefania and Derudas, Daniele and Giannotta, Claudia and Crippa, Claudia and Mancuso, Katia and Marcatti, Magda and Innocenti, Idanna and Mazza, Rita and Bramanti, Stefania and Laurenti, Luca},
title = {VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation},
journal = {Hematological Oncology},
year = {2025},
doi = {10.1002/hon.70049}
}
EUVIMED